Everything below concerns CJC-1295. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-06-16. Numbers and descriptions here follow the published literature rather than marketing material.
CJC-1295 is a synthetic peptide built as a long-acting analogue of growth hormone-releasing hormone. Its backbone matches the first twenty-nine residues of the natural human hormone, with four amino acid substitutions added to slow enzymatic breakdown. A reactive maleimide group, commonly termed the drug affinity complex, allows the peptide to attach to circulating albumin after administration. That albumin attachment keeps the molecule in the bloodstream for an extended period instead of being cleared within minutes.
The compound emerged from work at a Canadian biotechnology firm in the early 2000s. Early human studies examined its effect on growth hormone and insulin-like growth factor 1 in healthy volunteers and in people with HIV-associated fat redistribution. Reports described sustained increases in both markers after a single injection. Development did not advance to regulatory approval, and the clinical programme was later discontinued. The molecule is now encountered mainly as a research chemical rather than a marketed medicine.
Stability depends heavily on physical state. A lyophilized powder kept dry, desiccated, and shielded from light typically holds its integrity for months to years at minus twenty degrees Celsius, and longer at minus eighty. Once dissolved, the peptide becomes far more vulnerable, since peptide bond hydrolysis, oxidation of susceptible residues, and aggregation all proceed faster in solution. Buffers near neutral pH are generally gentler than strongly acidic or alkaline conditions. Repeated freeze-thaw cycles and exposure to air-liquid interfaces during vigorous mixing cause losses that are easy to overlook.
Verification matters because research peptides vary widely in quality. A certificate of analysis is only as reliable as the method behind it, and a single chromatographic trace reveals little about counter-ions, residual solvents, or water content. Independent laboratories commonly pair mass confirmation with chromatographic purity and, where relevant, quantify water along with acetate or trifluoroacetate content. Reported purity figures are not standardized across suppliers, so a stated value such as ninety-eight percent is not directly comparable unless the analytical method, column, and detection wavelength accompany it.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C152H252N44O42 | Cited for the form without the drug affinity complex |
| Molecular weight | About 3368 Da | Reported value for modified GRF(1-29) |
| Appearance | White to off-white powder | Lyophilised solid as usually supplied |
| Solubility | Soluble in water and polar solvents | Clarity depends on purity and salt content |
| Typical storage | -20 C or below, dry | Protect from light and repeated warming cycles |
CJC-1295 is a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. Its sequence corresponds to the first twenty-nine residues of human GHRH, with four substitutions that slow enzymatic breakdown. Early descriptions placed the compound in research on growth hormone deficiency and related conditions, and later literature groups it with the long-acting GHRH analogs. The name appears in both laboratory and popular fitness writing, where it sometimes labels chemically different peptides.
Two related peptides circulate under the CJC-1295 label, and they differ mainly in how long they persist in circulation. The version carrying a drug affinity complex includes a maleimidopropionic acid linker that forms a covalent bond with serum albumin. The other version, usually written as modified GRF(1-29) or tetrasubstituted GRF(1-29), lacks that linker and is cleared quickly. Mixing the two produces inconsistent readings of published half-life values, because the linker rather than the receptor-facing sequence drives most of the difference.
The core sequence keeps the receptor-binding region of GHRH while replacing four positions that are vulnerable to dipeptidyl peptidase-4 and other proteases. Substitutions at positions 2, 8, 15, and 27 raise metabolic stability relative to the natural hormone. The N-terminal residues remain essential for activity, so changes there generally lower potency. Molecular weight sits near 3368 daltons for the tetrasubstituted analog without the linker, while the albumin-binding form is heavier because of the added maleimide group.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
CJC-1295 is the name used for a synthetic peptide modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound was described by a Canadian drug discovery company in the mid-2000s as a long-acting research tool. Two closely related molecules share the name in practice: one carries a drug affinity complex, or DAC, group, and one does not. The distinction matters because the two behave differently in circulation.
Conservative leader Kemi Badenoch outlines her party's immigration policy, which reaffirms its commitment to a "strict migration cap"; she also says that her party got it "wrong" on immigration while in government. MPs will debate an online petition calling for a re-run of the 2024 general election in Westminster Hall, a secondary debating chamber, on 6 January 2025 after the petition attracted 2.8 million signatures. 28 November – Former prime minister David Cameron announces his support for an assisted dying law in the UK. Transport Secretary Louise Haigh reveals that she pleaded guilty to falsely saying a mobile phone had been stolen during a mugging before she became an MP and was given an absolute discharge by magistrates. Unite the Union announces plans to proceed with a legal challenge to overturn the UK government's cuts to Winter Fuel Payments. The Scottish Government announces that all pensioner households will receive a Winter Fuel Payment from Winter 2025–26, with those on Pension Credit receiving £200 or £300 dependent on age and the rest receiving £100. Former Conservative MP Andrea Jenkyns defects to Reform UK, and announces plans to run as Mayor of Greater Lincolnshire in May 2025. BBC News Wales reports that Senedd Conservatives will hold a vote of confidence in Welsh Conservative leader Andrew RT Davies on 3 December following a series of criticisms about his leadership. Mauritian prime minister Navin Ramgoolam asks for an independent review of the UK's deal with his country over sovereignty of the Chagos Islands.
=== Military garrisons and agricultural colonies === The first emperor Qin Shi Huang is said to have sent several hundred thousand men and fifteen thousand women to form agricultural and military settlements in Lingnan (present day Guangxi and Guangdong), under the leadership of a general named Zhao Tuo. The famous Han emperor, Han Wu Di, ordered another two hundred thousand men to build ships to attack and colonialize the Lingnan region, adding to the population in Guangdong and Guangxi. The first urban conurbations in the region, for example, Panyu, were created by Han settlers rather than the Bai Yue, who preferred to maintain small settlements subsisting on swidden agriculture and rice farming. Later on, Guangdong, northern Vietnam, and Yunnan all experienced a surge in Han Chinese migrants during Wang Mang's reign. The demographic composition and culture of these regions during this period, could however scarcely be said to have been Sinitic outside the confines of these agricultural settlements and military outposts.
ADP-ribose is an intermediate that is produced during the metabolism of NAD+, mono- or poly-unsaturated proteins, and cyclic-ADP ribose. ADP-ribose is a protein-glycating agent, and excess levels of ADP-ribose in the cell can cause non-enzymatic ADP-ribosylation. Non-enzymatic ADP-ribosylation can inactivate protein targets that contain nucleotide-binding sites when the adenylate moiety of ADP-ribose binds to them, and it can also interfere with metabolic regulation that occurs via enzymatic ADP-ribosylation. For example, actin polymerization is inhibited by non-enzymatic ADP-ribosylation at a Cys residue. Thus, it is believed that ADPRase functions in general as a house-cleaning enzyme to eliminate potentially deleterious ADP-ribose from the cell. In the literature, the detoxifying role of ADPRase is directly supported in E. coli cells. But in mammalian cells, there is only an indirect evidence linking ADPRase to a detoxifying role, and this comes from studies of the very specific rat liver ADPRibase-I by cytotoxic agents.
Wide range of genomic applications and scientific questions, including de novo genome assembly, haplotype phasing, structural variant analysis, and transcriptome and epigenetic analysis. Accuracy and scalability. Method requires small quantities of input DNA, which can be beneficial for small samples or single cell studies. More cost effective per sample in comparison with long-read technologies such as Oxford Nanopore sequencing. Libraries produced by linked-read can be processed using Illumina short read sequencing, increasing accessibility. Complexity of library construction - this technology requires high molecular DNA preparation in order to produce long enough DNA molecules for sequencing. Limitations in read length may result in limited haplotype resolution, which could reduce the efficacy of this technology in highly complex genomic regions.
Sources: en.wikipedia.org
Initially, phase II trials reported it was effective and well tolerated. Of the eight planned phase III clinical trials of weekly taspoglutide (four against exenatide, sitagliptin, insulin glargine, and pioglitazone), at least five were active in 2009. Preliminary results in early 2010 were favourable. (At least one of the eight planned phase III trials had not started recruiting by end 2009.) In September 2010 Roche halted Phase III clinical trials due to instances of serious hypersensitivity reactions and gastrointestinal side effects. As of May 2022 no new trials have been registered since 2010.
Trump's language became a further subject for concern throughout April. Various lengthy and expletive-laden Truth Social posts, including threats against Iran during the 2026 Iran war and rebukes of Pope Leo XIV, reignited debates over Trump's mental fitness. Self-professed "anti-MAGA" psychiatrist Geoff Grammer stated that "there's a large differential of things that it could be, including him feeling trapped and developing narcissistic rage [...] It could be that he's becoming disinhibited, but it could also be that he is just drifting to who he naturally is." Trauma therapist Shari Botwin speculated that the posts and previous explicit rebukes against allies and opponents were the result of strongly felt insecurities characteristic of narcissism, while Democratic representative Jasmine Crockett characterized Trump as "deranged, likely suffering from dementia" in a letter to vice president JD Vance. Republican representative and Trump opponent Marjorie Taylor Greene joined over 50 Democrats calling for the use of the 25th Amendment, stating that "I think we have to truly question the mental stability of any president that threatens to wipe out an entire civilization" in reference to a post issued on Easter day. On April 14, representative Jamie Raskin wrote the White House physician requesting a comprehensive neuropsychological assessment of the President, noting that "experts have repeatedly warned that the President has been exhibiting signs consistent with dementia and cognitive decline".
Canadian Learning Television, a former name of Oprah Winfrey Network Capitol Land Trust, Washington, USA Compagnie Luxembourgeoise de Radiodiffusion, later RTL Group, Luxembourg media company Culture Commission or "CLT Commission" affiliated with UNESCO
Sources: en.wikipedia.org
It is a synthetic peptide analogue of growth hormone-releasing hormone. Four substitutions in its sequence make it more resistant to enzymatic degradation than the natural hormone. In the version carrying a drug affinity complex, the peptide binds albumin and remains in circulation for days.
No regulatory agency has approved CJC-1295 for clinical use. Human trials were conducted in the 2000s, but the development programme was discontinued before any marketing application succeeded. Material sold today is offered as a research chemical, and its purity depends on the supplier.
Sermorelin is an unmodified fragment of growth hormone-releasing hormone and is cleared quickly. CJC-1295 contains substitutions that resist breakdown, and the form with a drug affinity complex persists much longer. Both act at the same receptor but differ substantially in duration of action.
Mass spectrometry establishes whether the observed molecular weight matches the calculated sequence mass. Chromatographic retention and fragment mapping add further confidence about sequence and composition. A single technique alone is rarely treated as sufficient evidence of identity.